Abbott Agrees $670 Million Settlement Over Preterm Infant Formula Claims

From Dispatch Room Abbott Laboratories has agreed to pay $670 million to settle claims brought by about 2,000 people who alleged that the company’s specialised formula products for premature babies were linked to a serious bowel disease. The agreement, announced on Thursday, covers claims handled by three law firms and includes a high-profile case in […]